Johnson & Johnson readies to resume COVID-19 vaccine trial in the US

Johnson & Johnson says it is preparing to resume recruitment in its Phase 3 Janssen COVID-19 vaccine trial in the US: after the trial was paused because of an unexplained illness earlier this month.